BAILLIE GIFFORD & CO – Alnylam Pharmaceuticals, Inc. Transaction History
BAILLIE GIFFORD & CO portfolio value:
$1.90B
portfolio value
BAILLIE GIFFORD & CO quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.55% | -453.67K shares | 450.57M | $200.16 | 9.51M |
| Q2 2022 | share | Decrease | -1.69% | -171.29K shares | -201.82M | $145.85 | 9.96M |
| Q1 2022 | share | Decrease | -4.49% | -477.02K shares | -144.67M | $163.29 | 10.13M |
| Q4 2021 | share | Increase | +1.93% | 200.96K shares | -166.21M | $171.03 | 10.61M |
| Q3 2021 | share | Increase | +1.87% | 190.92K shares | 233.28M | $188.81 | 10.41M |
| Q2 2021 | share | Increase | +1.49% | 149.89K shares | 310.83M | $169.52 | 10.22M |
| Q1 2021 | share | Increase | +10.32% | 942.54K shares | 235.54M | $141.19 | 10.07M |
| Q4 2020 | share | Increase | +2.71% | 240.93K shares | -107.65M | $129.97 | 9.13M |
| Q3 2020 | share | Increase | +2.81% | 242.81K shares | 13.64M | $145.6 | 8.89M |
| Q2 2020 | share | Increase | +2.82% | 236.90K shares | 365.33M | $148.11 | 8.64M |
| Q1 2020 | share | Increase | +2.75% | 225.04K shares | -27.24M | $108.85 | 8.41M |
| Q4 2019 | share | Decrease | -0.60% | -49.25K shares | 280.52M | $115.17 | 8.18M |
| Q3 2019 | share | Increase | +32.55% | 2.02M shares | 211.48M | $80.42 | 8.23M |
| Q2 2019 | share | Increase | +9.31% | 528.96K shares | -80.36M | $72.56 | 6.21M |
| Q1 2019 | share | Increase | +19.75% | 937.65K shares | 185.12M | $93.45 | 5.68M |
| Q4 2018 | share | Increase | +6.36% | 284.02K shares | -44.49M | $72.91 | 4.74M |
| Q3 2018 | share | Increase | +5.46% | 230.94K shares | -26.21M | $87.52 | 4.46M |
| Q2 2018 | share | Increase | +10.37% | 397.66K shares | -39.85M | $98.49 | 4.23M |
| Q1 2018 | share | Increase | +6.18% | 223.19K shares | -2.12M | $119.1 | 3.83M |
| Q4 2017 | share | Increase | +6.04% | 205.62K shares | 58.68M | $127.05 | 3.61M |
| Q3 2017 | share | Decrease | -0.76% | -25.92K shares | 126.41M | $117.49 | 3.40M |
| Q2 2017 | share | Increase | +2.90% | 96.80K shares | 102.78M | $79.76 | 3.43M |
| Q1 2017 | share | Increase | +0.50% | 16.48K shares | 46.66M | $51.25 | 3.33M |
| Q4 2016 | share | Decrease | -1.49% | -50.30K shares | -104.07M | $37.44 | 3.31M |
| Q3 2016 | share | Decrease | -0.65% | -21.92K shares | 40.18M | $67.78 | 3.36M |
| Q2 2016 | share | Increase | +0.31% | 10.31K shares | -24.03M | $55.49 | 3.39M |
| Q1 2016 | share | Increase | +23.91% | 652.20K shares | -44.63M | $62.77 | 3.37M |